Skip to main content

A plant-based vaccine from a GlaxoSmithKline alliance with Medicago shows strong antibody response

Trial participants have 10 times more antibodies in their systems than patients recovering from COVID-19.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.